Mirador Therapeutics
miradortx.com
Actively hiring
Oncology Therapeutics
Drug Discovery
View 1 job
Claim pageClaim
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$413M
2 rounds on record
Latest round
$333M
Venture round · Feb 2024 · 2 yr ago
Team
51-200
employees, estimated range
Hiring now
2
open roles
Backers
2
ARCH Venture Partners, OrbiMed
The money's age
Long since its last round
32 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 15, 2024
Raised a round Venture round $333M · SEC Form D
Dec 14, 2023
Raised a round Venture round $80M · SEC Form D
2023
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2024 | $333M | — | SEC Form D |
| Venture round | Dec 2023 | $80M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Mirador Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Timothy AndrewsExecutive OfficerSEC Form D
Mark McKennaExecutive Officer, DirectorSEC Form D
Vika BroughExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
ARCH Venture Partners 
OrbiMed Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Treeline Biosciences is a biotechnology company developing small-molecule medicines for cancer and immune diseases.
Magnet Biomedicine is advancing monovalent molecular glue inhibitors (MGIs) and innovative protein degraders to engage disease drivers.
Our Science Platform Pipeline REM-422 About Us Our Story Our People Our Investors Our Partners Join Us News News Presentations Press…
Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual…
Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families.
Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational…
Tech stack
Technologies named in job postings at Mirador Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
43/100
Practices & domains
Good Clinical Practice
Sign in to see how your skills match this stack
Sign In
People
Timothy Andrews
Executive Officer
Mark McKenna
Executive Officer, Director
Vika Brough
Executive Officer
Paul Berns
Director
David Bonita M.D.
Director
Scott Glenn
Director
Kristina Burow
Director
Joseph Papa
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
24/100
Hiring freeze
Open positions
2
0 opened / 0 closed in 30 days
Median time-to-fill
51 days
faster than 27% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
33% ▼
Early Careers
33% ▼
Biotech
33% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Diego
San Diego
United States
HQ
We're building something ambitious, and we're always open to conversations
3 open roles 3 posted in 90 days 33% remote 50-200 est. staff
hires for Early Careers, Biotech
Jobs
≈ $176k – $303k per year (Estimated) • Remote (United States) • 10+ years exp • PhD • San Diego
Good Clinical Practice
Apply